Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot–Marie–Tooth type 2AFederica Rizzo(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)Cellular and Molecular Life SciencesNovember 25, 202310.1007/s00018-023-05018-wCited by 20SaveCiteExport RISWatch citationsRelated PapersCombined RNA interference and gene replacement therapy targeting MFN2 for the treatment of Charcot-Marie-Tooth type 2A|Research Square|2023|0